34 - Postinduction MRD identifies patients with NPM1 AML who benefit from allogeneic transplant

Описание к видео 34 - Postinduction MRD identifies patients with NPM1 AML who benefit from allogeneic transplant

Discussão do artigo: "Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission " de Othman J Blood 2024

Apresentado por: Dra. Luana Pompeu

Discussão por: Dr. Rafael Faust, Dra. Camila Ferreira, Dr. Pedro Arruda e Dr. Vinicius Molla

Комментарии

Информация по комментариям в разработке